Profiel
Tom Ransohoff is President of BioFlash Partners LLC and Tarpon Biosystems.
He is Senior Consultant with BioProcess Technology Consultants.
Previously, Mr. Ransohoff held senior positions with business unit and operational responsibility at TranXenoGen, Dyax, Repligen, and Xoma.
He has over 20 years of experience in the biopharmaceutical industry.
Mr. Ransohoff received a Bachelor's degree in Chemical Engineering from Massachusetts Institute of Technology and a Master's degree in Chemical Engineering from University of California, Berkeley.
Eerdere bekende functies van Thomas C. Ransohoff
| Bedrijven | Functie | Einde |
|---|---|---|
| XOMA ROYALTY CORPORATION | Corporate Officer/Principal | - |
| REPLIGEN CORPORATION | Corporate Officer/Principal | - |
| DYAX CORP. | Corporate Officer/Principal | - |
TranXenoGen, Inc.
TranXenoGen, Inc. BiotechnologyHealth Technology Develops generic biologicals through transgenic animal production and cloning | Corporate Officer/Principal | - |
BioFlash Partners LLC
BioFlash Partners LLC Miscellaneous Commercial ServicesCommercial Services Provides bio technical research services | President | - |
Opleiding van Thomas C. Ransohoff
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Repligen Corp.
Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Dyax Corp.
Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
BioFlash Partners LLC
BioFlash Partners LLC Miscellaneous Commercial ServicesCommercial Services Provides bio technical research services | Commercial Services |
Tarpon Biosystems, Inc.
Tarpon Biosystems, Inc. BiotechnologyHealth Technology Develops BioSMB systems | Health Technology |
TranXenoGen, Inc.
TranXenoGen, Inc. BiotechnologyHealth Technology Develops generic biologicals through transgenic animal production and cloning | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















